Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis

It has been suggested that cytokine-mediated inflammation plays a key role for the onset and/or development of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic lateral sclerosis (ALS). However, clinical studies have yielded inconsisten...

Full description

Bibliographic Details
Main Authors: Xi Chen, Yang Hu, Zongze Cao, Qingshan Liu, Yong Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.02122/full
_version_ 1819101024555630592
author Xi Chen
Yang Hu
Zongze Cao
Qingshan Liu
Yong Cheng
author_facet Xi Chen
Yang Hu
Zongze Cao
Qingshan Liu
Yong Cheng
author_sort Xi Chen
collection DOAJ
description It has been suggested that cytokine-mediated inflammation plays a key role for the onset and/or development of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic lateral sclerosis (ALS). However, clinical studies have yielded inconsistent results for the aberrant cytokine levels in circulation of patients with AD, PD, and ALS. Previous studies have used meta-analysis to address the inconsistent data for blood cytokine levels in the patients with AD, PD, and ALS. Here, we performed a systemic review of cerebrospinal fluid inflammatory cytokine data in patients with AD, PD and ALS, and sought to quantitatively summarize the CSF inflammatory cytokine data with a meta-analytical technique. The systematic search from Pubmed and Web of Science identified 71 articles with 2629 patients and 2049 controls for the meta-analysis. Random-effects meta-analysis demonstrated that CSF TGF-β, MCP-1, and YKL-40 levels were significantly elevated in AD patients when compared with controls. In addition, patients with PD had heightened levels of TGF-β1, IL-6, and IL-1β in CSF. Furthermore, G-CSF, IL-2, IL-15, IL-17, MCP-1, MIP-1α, TNF-α, and VEGF levels were significantly increased in patients with ALS as compared with controls. Taken together, these results not only strengthen the clinical evidence that neurodegenerative diseases are accompanied by the increased inflammatory response, but also reveal the unique inflammatory response profile in the central nervous system of patients with AD, PD and ALS. Given the robust associations between some cytokines and neurodegenerative diseases found in this meta-analysis, CSF inflammatory cytokines may be used as biomarkers for these diseases in the future.
first_indexed 2024-12-22T01:12:06Z
format Article
id doaj.art-5027c400b7cb4e40abb0942be6ffb40f
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-22T01:12:06Z
publishDate 2018-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-5027c400b7cb4e40abb0942be6ffb40f2022-12-21T18:43:57ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-09-01910.3389/fimmu.2018.02122410228Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-AnalysisXi ChenYang HuZongze CaoQingshan LiuYong ChengIt has been suggested that cytokine-mediated inflammation plays a key role for the onset and/or development of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic lateral sclerosis (ALS). However, clinical studies have yielded inconsistent results for the aberrant cytokine levels in circulation of patients with AD, PD, and ALS. Previous studies have used meta-analysis to address the inconsistent data for blood cytokine levels in the patients with AD, PD, and ALS. Here, we performed a systemic review of cerebrospinal fluid inflammatory cytokine data in patients with AD, PD and ALS, and sought to quantitatively summarize the CSF inflammatory cytokine data with a meta-analytical technique. The systematic search from Pubmed and Web of Science identified 71 articles with 2629 patients and 2049 controls for the meta-analysis. Random-effects meta-analysis demonstrated that CSF TGF-β, MCP-1, and YKL-40 levels were significantly elevated in AD patients when compared with controls. In addition, patients with PD had heightened levels of TGF-β1, IL-6, and IL-1β in CSF. Furthermore, G-CSF, IL-2, IL-15, IL-17, MCP-1, MIP-1α, TNF-α, and VEGF levels were significantly increased in patients with ALS as compared with controls. Taken together, these results not only strengthen the clinical evidence that neurodegenerative diseases are accompanied by the increased inflammatory response, but also reveal the unique inflammatory response profile in the central nervous system of patients with AD, PD and ALS. Given the robust associations between some cytokines and neurodegenerative diseases found in this meta-analysis, CSF inflammatory cytokines may be used as biomarkers for these diseases in the future.https://www.frontiersin.org/article/10.3389/fimmu.2018.02122/fullinflammationcytokineneurodegenerative diseasescerebrospinal fluidmeta-analysis
spellingShingle Xi Chen
Yang Hu
Zongze Cao
Qingshan Liu
Yong Cheng
Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
Frontiers in Immunology
inflammation
cytokine
neurodegenerative diseases
cerebrospinal fluid
meta-analysis
title Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
title_full Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
title_fullStr Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
title_full_unstemmed Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
title_short Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
title_sort cerebrospinal fluid inflammatory cytokine aberrations in alzheimer s disease parkinson s disease and amyotrophic lateral sclerosis a systematic review and meta analysis
topic inflammation
cytokine
neurodegenerative diseases
cerebrospinal fluid
meta-analysis
url https://www.frontiersin.org/article/10.3389/fimmu.2018.02122/full
work_keys_str_mv AT xichen cerebrospinalfluidinflammatorycytokineaberrationsinalzheimersdiseaseparkinsonsdiseaseandamyotrophiclateralsclerosisasystematicreviewandmetaanalysis
AT yanghu cerebrospinalfluidinflammatorycytokineaberrationsinalzheimersdiseaseparkinsonsdiseaseandamyotrophiclateralsclerosisasystematicreviewandmetaanalysis
AT zongzecao cerebrospinalfluidinflammatorycytokineaberrationsinalzheimersdiseaseparkinsonsdiseaseandamyotrophiclateralsclerosisasystematicreviewandmetaanalysis
AT qingshanliu cerebrospinalfluidinflammatorycytokineaberrationsinalzheimersdiseaseparkinsonsdiseaseandamyotrophiclateralsclerosisasystematicreviewandmetaanalysis
AT yongcheng cerebrospinalfluidinflammatorycytokineaberrationsinalzheimersdiseaseparkinsonsdiseaseandamyotrophiclateralsclerosisasystematicreviewandmetaanalysis